Verastem (VSTM) Share-based Compensation (2011 - 2026)
Verastem (VSTM) posted quarterly Share-based Compensation of $2.5 million for Q1 2026, up 40.66% year-over-year from $1.8 million in Q1 2025, and up 24.2% quarter-over-quarter from $2.0 million in Q4 2025.
Analysis
Verastem (VSTM) Share-based Compensation (2011 - 2026) Analysis & Trends
Verastem's Share-based Compensation history runs 16 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 40.66% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $10.1 million (up 683.53% YoY), while the FY2025 annual figure was $9.4 million, up 851.82% from the prior year.
- Share-based Compensation for Q1 2026 stood at $2.5 million, up from $2.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $3.4 million in Q2 2025, with the low at -$4.3 million in Q4 2024.
- The 5-year median for Share-based Compensation is $1.6 million (2022), against an average of $1.5 million.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation tumbled 371.28% in 2024, then jumped 146.71% in 2025.
- Verastem's Share-based Compensation stood at $1.3 million in 2022, then gained by 24.16% to $1.6 million in 2023, then sank by 371.28% to -$4.3 million in 2024, then surged by 146.71% to $2.0 million in 2025, then advanced by 24.2% to $2.5 million in 2026.
- Business Quant data shows VSTM's Share-based Compensation at $2.5 million in Q1 2026, $2.0 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 120.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 277.20 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 137.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Verastem | 815.95 Mn | 679.59 Mn | 36.32 Mn | 3.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 3.33 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.96 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 2.12 Mn |
| Jun 30, 2023 | 2.01 Mn |
| Mar 31, 2023 | 23.72 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 13.65 Mn |
| Jun 30, 2022 | 16.54 Mn |
| Mar 31, 2022 | 15.94 Mn |
| Dec 31, 2021 | 1.57 Mn |
| Sep 30, 2021 | 12.95 Mn |